NCT06764316
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06764316
Title A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
Acronym BANTAM-01
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | FIN | ESP | CAN | BEL

Facility Status City State Zip Country Details
Edegem RECRUITING Edegem 2650 Belgium Details
Kortrijk RECRUITING Kortrijk 8500 Belgium Details
Leuven RECRUITING Leuven 3000 Belgium Details
Toronto RECRUITING Toronto Ontario M5G 2C4 Canada Details
Montréal RECRUITING Montreal Quebec H2X 0C1 Canada Details
Montreal RECRUITING Montreal Quebec H4A 3J1 Canada Details
Sherbrooke RECRUITING Sherbrooke Quebec J1H 5N4 Canada Details
Tampere RECRUITING Tampere Pirkanmaa 33520 Finland Details
Turku RECRUITING Turku Southwest Finland 20540 Finland Details
Madrid RECRUITING Madrid 28050 Spain Details
London RECRUITING London Greater London W12 0HS United Kingdom Details
Glasgow RECRUITING Glasgow Scotland G12 0YN United Kingdom Details
Sutton RECRUITING Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field